App Shopper: Multiple Sclerosis Diagnosis & Management (Medical)

App Activity

May 18 '13	Version 2.0
Nov 28 '12	Version 1.3
Oct 03 '12	Version 1.2
Dec 03 '11	Version 1.1
Nov 19 '11	New App: Free, v1.0

About AppShopper

For more information on Contacting Us, App Submissions, and Advertising, visit our About page

Multiple Sclerosis Diagnosis & Management

iOS Universal

The Multiple Sclerosis - Clinical Care App contains current information on the diagnosis, classification, and management of multiple sclerosis (MS), concisely presented for use at the point of care. The content has been developed by Borm Bruckmeier Publishing in collaboration with the National MS Society, and is intended for practicing neurologists, resident physicians and other healthcare professionals involved in the management of patients with multiple sclerosis.

  Highlights include:
 · Signs and symptoms characteristic of MS 
· Four disease courses 
· 2010 Revised McDonald Diagnostic Criteria for Multiple Sclerosis 
· Differential diagnoses
 · Elements of the diagnostic workup, including typical findings on brain and spinal MRI, and cerebrospinal fluid analysis
 · Common clinically-isolated syndrome presentations
· Extensive symptom management including impact on quality of life, additional resources, and patient education material
 · Treatment strategies including disease-modifying medications and relapse and symptom management
 · Assessment scales including the Kurtzke Functional Systems Scores, Kurtzke Expanded Disability Status Scale, Bladder Control Scale, and Two-Question Screening Tool for Depression
 · National MS Society resources for clinicians and their patients

What's new

What's New in Version 1.3
Teriflunomide (Aubagio®) was added under “Treating Multiple Sclerosis”

What's New in Version 2.0
New design with improved user experience Extensive symptom management including impact on quality of life, additional resources, and patient education material Symptoms include ambulation problems, bladder dysfunction, bowel dysfunction, cognitive dysfunction, dysphagia, fatigue, mood changes, pain/sensory problems, spasticity, tremor, vertigo, visual impairment Option to send patient education material via email Prof. eNewsletter signup Social media links Dimethyl fumarate (Tecfidera®) was added under “Treating Multiple Sclerosis”